You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Sale Disclosure
Torley Helen · SEC Form 4 · Filed Jul 9, 2026
Sale
Calculated transaction value
$82.99K
Torley Helen President And CEO
HALO
Transaction date
Jul 8, 2026
Public filing date
Jul 9, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$80.37
Jul 8, 2026
First close after public filing
$76.2
Jul 10, 2026
30-day return after filing
+34.67%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,035 shares @ $80.19
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000100
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$199.81K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Exercise | Jul 8, 2026 | $23.21K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jul 8, 2026 | $70.4K |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Jul 8, 2026 | $82.99K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jul 8, 2026 | $23.21K |